Return to Article Details
COMPARISON OF EMPAGLIFLOZIN AND DAPAGLIFLOZIN IN HEART FAILURE IN DIABETIC PATIENTS TAKING SODIUM-GLUCOSE COTRANSPORTER-2 AND ANGIOTENSIN RECEPTOR NEPRILYSIN INHIBITOR
Download
Download PDF